Lawmakers and regulators (and presidential hopefuls) have been ramping up their scrutiny of drug
pricing practices amid several flagrant instances of alleged price gouging (see Turing Pharmaceuticalsand Valeant), and consumer advocates are becoming more vocal about the price of even generic pharmaceuticals.